chr19-38505426-A-G

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4BA1BP7

This summary comes from the ClinGen Evidence Repository: The variant NM_000540.3:c.8400+28A>G in RYR1 is an intronic variant located in intron 53. The filtering allele frequency (the lower threshold of the 95% CI of 37922/85572, 8751 homozygotes) of the c.8400+28A>G variant in RYR1 is 0.4383 for South Asian chromosomes by gnomAD v4.1, which is higher than the ClinGen Congenital Myopathies VCEP threshold (≥0.00697) for BA1, and therefore meets this criterion (BA1). The c.8400+28A>G variant is an intronic variant that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved as shown by UCSC Genome Browser (BP4, BP7). In summary, the variant meets criteria to be classified as benign. ACMG/AMP criteria met, as specified by the congenital myopathies VCEP: BA1, BP4, BP7 (ClinGen Congenital Myopathies VCEP specifications version 1; 8/7/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA024918/MONDO:0100150/179

Frequency

Genomes: 𝑓 0.33 ( 8637 hom., cov: 31)
Exomes 𝑓: 0.27 ( 53110 hom. )

Consequence

RYR1
NM_000540.3 intron

Scores

2

Clinical Significance

Benign reviewed by expert panel B:7O:1

Conservation

PhyloP100: 0.874

Publications

8 publications found
Variant links:
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
RYR1 Gene-Disease associations (from GenCC):
  • malignant hyperthermia, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Ambry Genetics, ClinGen
  • RYR1-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia
  • congenital multicore myopathy with external ophthalmoplegia
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • central core myopathy
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • King-Denborough syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant hyperthermia of anesthesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • benign Samaritan congenital myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital myopathy with myasthenic-like onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BP7
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000540.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RYR1
NM_000540.3
MANE Select
c.8400+28A>G
intron
N/ANP_000531.2P21817-1
RYR1
NM_001042723.2
c.8400+28A>G
intron
N/ANP_001036188.1P21817-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RYR1
ENST00000359596.8
TSL:5 MANE Select
c.8400+28A>G
intron
N/AENSP00000352608.2P21817-1
RYR1
ENST00000355481.8
TSL:1
c.8400+28A>G
intron
N/AENSP00000347667.3P21817-2
RYR1
ENST00000594335.6
TSL:1
n.8400+28A>G
intron
N/AENSP00000470927.2M0R014

Frequencies

GnomAD3 genomes
AF:
0.326
AC:
49483
AN:
151922
Hom.:
8602
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.430
Gnomad AMI
AF:
0.258
Gnomad AMR
AF:
0.355
Gnomad ASJ
AF:
0.257
Gnomad EAS
AF:
0.362
Gnomad SAS
AF:
0.460
Gnomad FIN
AF:
0.289
Gnomad MID
AF:
0.316
Gnomad NFE
AF:
0.253
Gnomad OTH
AF:
0.333
GnomAD2 exomes
AF:
0.314
AC:
63093
AN:
200948
AF XY:
0.314
show subpopulations
Gnomad AFR exome
AF:
0.419
Gnomad AMR exome
AF:
0.382
Gnomad ASJ exome
AF:
0.241
Gnomad EAS exome
AF:
0.327
Gnomad FIN exome
AF:
0.291
Gnomad NFE exome
AF:
0.245
Gnomad OTH exome
AF:
0.302
GnomAD4 exome
AF:
0.271
AC:
367589
AN:
1356708
Hom.:
53110
Cov.:
22
AF XY:
0.276
AC XY:
186516
AN XY:
676690
show subpopulations
African (AFR)
AF:
0.428
AC:
13249
AN:
30952
American (AMR)
AF:
0.378
AC:
15162
AN:
40158
Ashkenazi Jewish (ASJ)
AF:
0.250
AC:
6284
AN:
25106
East Asian (EAS)
AF:
0.333
AC:
12673
AN:
38026
South Asian (SAS)
AF:
0.442
AC:
35712
AN:
80776
European-Finnish (FIN)
AF:
0.290
AC:
14814
AN:
51102
Middle Eastern (MID)
AF:
0.332
AC:
1799
AN:
5418
European-Non Finnish (NFE)
AF:
0.244
AC:
251442
AN:
1028528
Other (OTH)
AF:
0.290
AC:
16454
AN:
56642
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
11300
22601
33901
45202
56502
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8570
17140
25710
34280
42850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.326
AC:
49579
AN:
152040
Hom.:
8637
Cov.:
31
AF XY:
0.333
AC XY:
24760
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.431
AC:
17870
AN:
41442
American (AMR)
AF:
0.355
AC:
5426
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.257
AC:
893
AN:
3472
East Asian (EAS)
AF:
0.361
AC:
1866
AN:
5162
South Asian (SAS)
AF:
0.461
AC:
2210
AN:
4796
European-Finnish (FIN)
AF:
0.289
AC:
3058
AN:
10584
Middle Eastern (MID)
AF:
0.313
AC:
92
AN:
294
European-Non Finnish (NFE)
AF:
0.253
AC:
17216
AN:
67998
Other (OTH)
AF:
0.338
AC:
715
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1696
3392
5088
6784
8480
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
492
984
1476
1968
2460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.283
Hom.:
4194
Bravo
AF:
0.333
Asia WGS
AF:
0.487
AC:
1691
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (3)
-
-
1
Central core myopathy (1)
-
-
1
Congenital multicore myopathy with external ophthalmoplegia (1)
-
-
1
King Denborough syndrome (1)
-
-
1
not specified (1)
-
-
1
RYR1-related myopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
9.1
DANN
Benign
0.77
PhyloP100
0.87
Mutation Taster
=32/68
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2915953; hg19: chr19-38996066; COSMIC: COSV62092754; API